| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |